≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Explicit fungal Sepsis

Endpoint Browser

AB1_SEPSIS_FUNGAL_EXPL

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — B37.7
  • Hospital discharge: ICD-9 — 1125A
  • Cause of death: ICD-10 — B37.7
  • Cause of death: ICD-9 — 1125A

2 out of 7 registries used, show all original rules.

220

4. Check minimum number of events

None

220

5. Include endpoints

None

220

6. Filter based on genotype QC (FinnGen only)

220

Control definitions (FinnGen only)

Control exclude
AB1_SEPSIS_EXPLICIT, AB1_SEPSIS_IMPLICIT

Extra metadata

First used in FinnGen datafreeze
DF8

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 220 80 140
Unadjusted period prevalence (%) 0.05 0.03 0.06
Median age at first event (years) 64.89 61.22 66.99

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
192
Matched controls
1919
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B37.7
ICD-10 Finland
Candidal sepsis
+∞
266.1
188
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
17.7
59.3
105
122
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
32.1
57.2
77
39
A41.9
ICD-10 Finland
Sepsis, unspecified
+∞
56.0
51
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
15.8
43.4
76
76
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
480.5
40.7
39
*
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
227.6
37.2
37
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
10.5
36.7
81
125
A41.8
ICD-10 Finland
Other specified sepsis
+∞
36.6
34
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
35.1
35.8
46
17
ZXD05
NOMESCO Finland
Urgent procedure
7.3
35.6
118
342
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
10.4
34.7
76
114
J18.9
ICD-10 Finland
Pneumonia, unspecified
7.3
32.0
96
232
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
10.3
31.5
68
97
TPH07
NOMESCO Finland
Cathetrisation of artery
11.2
29.7
60
75
N17.9
ICD-10 Finland
Acute renal failure, unspecified
58.6
29.5
34
7
N02AA05
ATC
oxycodone; systemic
8.5
29.2
72
127
R50.9
ICD-10 Finland
Fever, unspecified
8.4
27.4
67
115
WX872
NOMESCO Finland
Intensive care
18.3
26.2
41
28
J01MA12
ATC
levofloxacin; systemic
6.5
25.9
80
190
JN4BD
NOMESCO Finland
Extensive body CT
7.6
25.0
65
121
TPX10
NOMESCO Finland
Implantation of vascular injection port
27.2
24.9
34
15
AA1AD
NOMESCO Finland
CT of head and brain
5.9
24.9
85
227
WX408
NOMESCO Finland
General anesthesy, balanced
5.6
24.9
93
277
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
10.8
24.3
49
59
JN3AD
NOMESCO Finland
Abdominal CT examination
10.4
23.9
49
61
JN3BD
NOMESCO Finland
Extensive abdominal CT
8.9
23.7
54
81
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
8.5
23.1
54
84
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.7
22.4
126
557
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
+∞
22.3
21
*
C03CA01
ATC
furosemide; systemic
4.8
21.2
92
310
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
18.0
20.6
32
21
JN4AD
NOMESCO Finland
Body CT examination
9.0
20.3
45
63
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.6
20.2
91
315
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
82.1
20.1
22
*
TK800
NOMESCO Finland
Hemodialysis
45.3
20.0
24
6
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
10.5
19.9
40
47
WX892
NOMESCO Finland
Monitored bed care
9.5
19.7
42
55
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
+∞
19.1
18
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.8
18.2
72
214
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
197.5
17.8
18
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
6.5
17.2
48
94
JAH00
NOMESCO Finland
Laparotomy
18.6
17.1
26
16
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.1
17.1
61
161
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
20.9
16.5
24
13
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.8
16.4
36
49
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.3
15.6
33
42
WW500
NOMESCO Finland
Blood transfusion
11.6
15.6
29
29
N03AX16
ATC
pregabalin; oral
4.2
15.5
71
237
J01MA02
ATC
ciprofloxacin; systemic
3.6
15.4
102
462
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
6.3
15.3
43
84
N18.8
ICD-10 Finland
Other chronic renal failure
20.5
15.1
22
12
J02AC01
ATC
fluconazole; systemic
3.6
14.9
94
408
R11
ICD-10 Finland
Nausea and vomiting
7.7
14.7
35
54
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
39.4
14.7
18
5
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
14.3
54
148
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
4.0
14.1
67
229
WX002
NOMESCO Finland
Sedation and analgesia
4.1
14.0
63
204
A06AD11
ATC
lactulose; oral
4.8
13.7
49
127
J01MA14
ATC
moxifloxacin; systemic
5.7
13.6
41
87
L89
ICD-10 Finland
Decubitus ulcer and pressure area
43.4
13.4
16
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
7.7
13.2
31
47
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
13.2
33
55
A03FA01
ATC
metoclopramide; systemic, rectal
3.8
13.1
65
228
SPAT1255
SPAT
Intravenous administration of medicine
7.9
13.0
30
44
D64.9
ICD-10 Finland
Anaemia, unspecified
5.1
13.0
43
102
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.7
13.0
28
37
WX882
NOMESCO Finland
High dependency care
11.3
12.9
24
24
JFB00
NOMESCO Finland
Partial resection of small intestine
34.7
12.8
16
5
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
12.9
12.7
22
19
A10AE04
ATC
insulin glargine; parenteral
6.0
12.7
36
71
GD1AD
NOMESCO Finland
Thorax CT examination
10.8
12.7
24
25
SPAT1262
SPAT
Handing over of treatment supplies
3.9
12.5
59
197
TQW11
NOMESCO Finland
Vacuum treatment of wound
19.7
12.3
18
10
UKC02
NOMESCO Finland
Cystoscopy
3.8
12.3
59
200
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.7
12.1
23
24
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
6.3
11.9
32
59
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
11.7
42
108
J96.0
ICD-10 Finland
Acute respiratory failure
+∞
11.6
11
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.7
11.6
58
203
GBB00
NOMESCO Finland
Tracheostomy
37.5
11.4
14
*
WX730
NOMESCO Finland
Conventional respirator
37.5
11.4
14
*
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
18.5
11.4
17
10
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
9.5
11.4
23
27
J01FF01
ATC
clindamycin; systemic
3.3
11.4
70
285
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.0
11.2
25
35
R31
ICD-10 Finland
Unspecified haematuria
4.5
11.2
42
113
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.0
11.1
82
379
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
8.9
11.0
23
29
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
12.3
10.8
19
17
A02BC02
ATC
pantoprazole; systemic
2.9
10.7
133
845
R33
ICD-10 Finland
Retention of urine
5.2
10.5
33
73
N17.8
ICD-10 Finland
Other acute renal failure
116.1
10.5
11
*
KA3EB
NOMESCO Finland
Antegrade pyelography
116.1
10.5
11
*
X59
ICD-10 Finland
Exposure to unspecified factor
3.6
10.5
53
185
N30.0
ICD-10 Finland
Acute cystitis
4.4
10.5
40
109
JDB10
NOMESCO Finland
Percutaneous gastrostomy
20.2
10.4
15
8
N02AX02
ATC
tramadol; systemic, rectal
2.8
10.4
100
540
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
25.0
10.4
14
6
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.1
10.3
28
52
C07AB07
ATC
bisoprolol; oral
2.7
10.3
112
648
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.3
10.1
31
67
J04AB02
ATC
rifampicin; systemic
42.5
10.1
12
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
11.6
10.0
18
17
B99
ICD-10 Finland
Other and unspecified infectious diseases
21.4
10.0
14
7
B03XA02
ATC
darbepoetin alfa; parenteral
27.7
9.9
13
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
5.2
9.8
31
69
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.6
9.8
35
89
B01AB10
ATC
tinzaparin; parenteral
6.2
9.8
26
47
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
12.3
9.8
17
15
B01AB05
ATC
enoxaparin; parenteral
2.9
9.8
75
349
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
58.0
9.8
11
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
16.1
9.7
15
10
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.0
9.7
65
277
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.1
9.6
23
36
XW000
NOMESCO Finland
Bone marrow biopsy
7.1
9.6
23
36
E87.5
ICD-10 Finland
Hyperkalaemia
18.7
9.6
14
8
ZZA00
NOMESCO Finland
Split skin graft
13.3
9.6
16
13
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
13.3
9.6
16
13
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
13.3
9.6
16
13
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
9.5
36
97
JAH33
NOMESCO Finland
Opening of laparostomy
105.0
9.5
10
*
TPX15
NOMESCO Finland
Removal of vascular injection port
105.0
9.5
10
*
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
105.0
9.5
10
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
23.1
9.5
13
6
A40.8
ICD-10 Finland
Other streptococcal sepsis
+∞
9.4
9
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
9.4
29
63
103
Kela drug reimbursment
Diabetes, insulin-treated
2.9
9.3
70
317
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.9
9.3
40
122
R53
ICD-10 Finland
Malaise and fatigue
3.4
9.2
47
165
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
6.6
9.1
23
39
E86
ICD-10 Finland
Volume depletion
13.4
9.0
15
12
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
9.0
49
179
ZX120
NOMESCO Finland
Intravenous
4.5
9.0
32
81
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
7.2
9.0
21
32
WX704
NOMESCO Finland
Intubation
6.4
8.9
23
40
S97
ICPC
Chronic ulcer skin
7.6
8.8
20
29
J01XX08
ATC
linezolid; systemic
52.4
8.8
10
*
Z49.1
ICD-10 Finland
Extracorporeal dialysis
52.4
8.8
10
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.3
8.6
20
30
A07AA02
ATC
nystatin; oral
6.1
8.6
23
42
V03AE01
ATC
polystyrene sulfonate; oral
29.0
8.6
11
*
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
94.0
8.5
9
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
94.0
8.5
9
*
JFF13
NOMESCO Finland
Terminal enterostomy
94.0
8.5
9
*
A11CC03
ATC
alfacalcidol; systemic
11.5
8.5
15
14
UJD02
NOMESCO Finland
Gastroscopy
6.2
8.4
22
39
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
6.2
8.4
22
39
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
+∞
8.4
8
*
A04AA01
ATC
ondansetron; systemic, rectal
5.6
8.4
24
48
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.0
8.4
53
215
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
8.3
77
390
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
15.4
8.3
13
9
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
15.4
8.3
13
9
ZXE00
NOMESCO Finland
One hour or less
2.5
8.3
89
491
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
8.3
84
449
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.8
8.3
17
21
E87.6
ICD-10 Finland
Hypokalaemia
12.5
8.2
14
12
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.5
8.2
14
12
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
18.2
8.2
12
7
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
4.6
8.1
28
69
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
23.2
8.1
11
5
K65.0
ICD-10 Finland
Acute peritonitis
23.2
8.1
11
5
SPAT1254
SPAT
Administration of medicine
3.5
8.1
39
130
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
8.4
8.1
17
22
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
13.8
8.0
13
10
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.8
8.0
22
42
WX725
NOMESCO Finland
Noninvasive ventilation
7.5
8.0
18
26
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.2
8.0
24
51
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.4
7.9
20
34
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.5
7.9
14
13
N05BA04
ATC
oxazepam; oral
2.7
7.9
61
280
A28
ICPC
Limited function/disability NOS
3.5
7.9
37
121
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
15.9
7.8
12
8
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
4.9
7.8
25
57
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
46.9
7.8
9
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
6.3
7.8
20
35
A46
ICD-10 Finland
Erysipelas
3.4
7.7
39
135
KA1AE
NOMESCO Finland
Kidney ultrasound examination
10.7
7.7
14
14
A10AE05
ATC
insulin detemir; parenteral
6.1
7.6
20
36
N05AH03
ATC
olanzapine; systemic
6.1
7.6
20
36
Z2446
NOMESCO Finland
Social worker
5.4
7.6
22
45
R55
ICD-10 Finland
Syncope and collapse
5.4
7.6
22
45
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
8.2
7.6
16
21
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.1
7.5
29
80
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
14.1
7.5
12
9
127
Kela drug reimbursment
Transplant complication
14.1
7.5
12
9
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
14.1
7.5
12
9
R4190
NOMESCO Finland
Nutritional therapy
7.3
7.5
17
25
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
83.2
7.5
8
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.3
7.5
27
70
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
10.0
7.4
14
15
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.4
7.3
26
66
JFA70
NOMESCO Finland
Suture of small intestine
+∞
7.3
7
*
TK810
NOMESCO Finland
Hemofiltration
+∞
7.3
7
*
NHQ40
NOMESCO Finland
Amputation of toe
16.6
7.3
11
7
A04AA02
ATC
granisetron; systemic, transdermal
5.2
7.3
22
47
N05AA02
ATC
levomepromazine; systemic
7.1
7.3
17
26
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
6.1
7.3
19
34
T36
ICD-10 Finland
Poisoning by systemic antibiotics
8.5
7.3
15
19
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
8.5
7.3
15
19
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
31.3
7.2
9
*
B18.2
ICD-10 Finland
Chronic viral hepatitis C
31.3
7.2
9
*
L28
ICPC
Limited function/disability (L)
3.2
7.2
39
140
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
14.5
7.0
11
8
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
6.1
7.0
18
32
P01AB01
ATC
metronidazole; oral, rectal
2.3
6.9
80
449
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.6
6.8
57
269
KBV00
NOMESCO Finland
Insertion of stent into ureter
41.6
6.8
8
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
6.8
22
51
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.9
6.8
18
33
A07AA09
ATC
vancomycin; oral
23.5
6.7
9
*
Z93.3
ICD-10 Finland
Colostomy status
23.5
6.7
9
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
23.5
6.7
9
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.6
6.5
18
35
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
15.0
6.5
10
7
Z72.2
ICD-10 Finland
Drug use
72.1
6.5
7
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
72.1
6.5
7
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
72.1
6.5
7
*
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
72.1
6.5
7
*
WW200
NOMESCO Finland
Immunization
8.6
6.4
13
16
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
9.8
6.4
12
13
K92.1
ICD-10 Finland
Melaena
4.8
6.4
20
45
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
6.4
39
152
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
11.6
6.4
11
10
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
18.8
6.3
9
5
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
18.8
6.3
9
5
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.0
6.3
19
41
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
+∞
6.3
6
*
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
+∞
6.3
6
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
+∞
6.3
6
*
Z93.2
ICD-10 Finland
Ileostomy status
+∞
6.3
6
*
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
+∞
6.3
6
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.0
6.3
24
66
TKC20
NOMESCO Finland
Catheterisation of bladder
4.1
6.3
23
61
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
5.5
6.2
17
33
SPAT1167
SPAT
Insertion of urinary catheter
7.1
6.2
14
21
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
13.1
6.2
10
8
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
13.1
6.2
10
8
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
13.1
6.2
10
8
L04AA06
ATC
mycophenolic acid; systemic
13.1
6.2
10
8
K29.7
ICD-10 Finland
Gastritis, unspecified
9.1
6.2
12
14
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
9.1
6.2
12
14
B01AA03
ATC
warfarin; systemic
2.6
6.1
51
237
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.8
6.1
41
169
UDQ12
NOMESCO Finland
Flexible laryngoscopy
5.1
6.1
18
38
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.1
6.1
18
38
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.4
6.1
29
96
N05CD07
ATC
temazepam; oral
3.0
6.0
35
133
F29
ICD-10 Finland
Unspecified nonorganic psychosis
7.7
6.0
13
18

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020779) Urea [Moles/volume] in Serum or Plasma
103
120
15.26
89.15
20.9
5.3
mmol/l
11.7
8.7
2.61
98
113
(3003458) Phosphate [Moles/volume] in Serum or Plasma
117
194
11.75
76.83
17.6
4.7
mmol/l
1.1
1.0
2.20
112
178
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
86
99
13.62
73.90
3.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
155
440
9.54
60.35
29.1
3.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
58
52
14.79
57.77
3.4
1.7
ug/l
1.6
0.3
1.77
53
45
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
47
30
19.65
56.29
6.6
1.7
u/ml
0.2
0.4
1.02
29
15
(3042936) Bacteria identified in Isolate by Culture
109
245
7.84
51.92
5.9
1.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
61
76
10.72
48.20
1.8
1.9
g/l
1.7
1.4
0.83
55
63
(3007853) Bacteria identified in Skin by Aerobe culture
92
188
7.69
47.55
3.7
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
77
142
7.80
43.49
20.3
3.2
mmol/l
2.0
1.7
0.23
66
111
(3023520) Reticulocytes [#/volume] in Blood
73
143
7.14
38.54
4.3
2.3
e9/l
67.8
67.5
0.03
57
116
(3000991) Gas panel - Venous blood
68
124
7.49
38.45
39.7
5.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
82
202
5.88
33.69
4.1
2.6
%
1.9
1.7
0.46
72
180
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
32
27
13.70
32.36
2.1
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
93
266
5.32
31.97
3.9
1.7
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
137
555
4.89
29.96
19.2
5.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
72
177
5.56
29.24
30.5
4.9
mmol/l
1.0
1.2
0.12
63
136
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
81
221
5.22
29.13
6.2
2.1
%
18.8
23.0
1.41
69
192
(3026008) Bacteria identified in Urine by Culture
120
448
4.69
28.99
8.0
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
72
182
5.39
28.23
3.3
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
115
424
4.59
28.05
4.3
1.9
mg/l
3.7
3.1
1.07
104
364
(3022948) Iron [Moles/volume] in Serum or Plasma
88
264
4.89
28.05
5.8
2.1
umol/l
8.9
13.2
5.41
80
244
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
130
533
4.52
27.30
6.4
2.3
u/l
63.5
56.2
0.47
119
492
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
71
184
5.22
26.93
3.4
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
36
47
8.96
26.75
2.1
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
36
10.23
26.62
2.0
1.6
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
81
236
4.85
26.61
6.1
2.1
g/l
2.0
2.3
4.91
75
220
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
28
26
12.19
26.53
2.0
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
32
37
9.95
26.08
2.2
1.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
50
102
6.05
24.60
9.5
2.8
mmol/l
1.8
1.6
0.12
33
77
(3009343) pH of Capillary blood
51
107
5.90
24.35
10.1
2.8
ph
7.4
7.4
—
9
8
(3024561) Albumin [Mass/volume] in Serum or Plasma
152
739
4.42
24.31
26.0
4.2
g/l
29.6
35.9
21.47
145
696
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
33
45
8.45
23.58
2.4
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
160
823
4.46
23.25
34.1
5.5
mmol/l
1.2
1.2
2.19
137
697
(3020630) Protein [Mass/volume] in Serum or Plasma
52
116
5.56
23.16
2.1
2.2
g/l
59.6
67.1
4.43
46
107
(3032080) INR in Blood by Coagulation assay
144
691
4.14
23.05
26.8
8.4
inr
1.3
1.3
0.04
37
219
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
45
90
6.03
22.51
1.9
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
42
80
6.25
22.07
36.0
5.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
150
756
4.09
21.99
33.9
4.6
mmol/l
1.2
1.2
1.93
141
681
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
167
914
4.43
21.54
25.4
5.5
umol/l
11.9
11.3
0.23
160
866
(3024928) Oxygen saturation in Venous blood
25
27
10.32
21.28
15.5
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
22
11.56
21.25
2.1
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
21
11.53
20.33
1.4
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
117
520
3.67
20.30
10.5
2.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
20
17
12.84
19.85
2.2
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
77
263
3.97
19.76
2.7
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
44
97
5.42
19.70
18.3
3.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
63
190
4.25
19.16
12.2
2.6
umol/l
6.7
8.3
0.48
52
167
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
29
9.17
18.75
1.6
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
86
328
3.66
18.60
6.5
2.4
mosm/kgh2o
480.3
583.3
5.16
79
274
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
60
179
4.23
18.46
7.5
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
145
772
3.58
18.30
15.5
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
95
392
3.51
18.09
10.1
2.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
51
137
4.54
17.96
3.8
1.9
g/l
9.8
10.6
0.36
46
123
(3000494) Fungus identified in Specimen by Culture
64
204
4.01
17.94
2.9
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
23
28
9.06
17.84
1.6
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
110
502
3.38
17.72
3.9
2.0
u/l
193.4
256.6
0.40
104
471
(3004588) Protein electrophoresis panel - Serum or Plasma
40
91
5.15
17.18
1.5
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
122
605
3.28
16.90
9.4
3.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
60
190
3.97
16.88
2.5
1.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
27
44
6.85
16.35
1.5
2.8
—
3.8
—
0
6
(3034860) Kappa light chains.free [Mass/volume] in Serum
27
45
6.70
16.00
1.7
2.9
mg/l
90.8
170.1
0.26
22
38
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
27
45
6.70
16.00
1.6
2.9
mg/l
57.1
27.5
2.02
22
38
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
21
9.81
15.78
1.8
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
108
516
3.15
15.64
15.1
3.5
ph
7.4
7.4
0.22
26
95
(1616796) Gas panel - Central venous blood
22
30
8.04
15.54
12.1
2.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
148
851
3.26
15.41
20.5
5.4
e9/l
0.7
0.6
5.29
141
736
(3006315) Basophils [#/volume] in Blood
148
853
3.25
15.30
20.6
5.5
e9/l
0.0
0.0
0.37
141
743
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
63
220
3.61
15.23
2.6
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
10
14.88
15.18
3.8
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
17
17
10.75
15.10
1.8
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
127
677
3.07
14.97
6.9
2.4
ug/l
401.9
129.3
1.93
118
616
(3019198) Lymphocytes [#/volume] in Blood
149
873
3.19
14.76
20.8
5.5
e9/l
2.1
1.9
0.18
144
775
(3019309) Folate [Moles/volume] in Red Blood Cells
78
318
3.25
14.67
2.1
1.7
nmol/l
1182.1
1169.3
0.04
59
243
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
20
26
8.36
14.67
2.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
20
26
8.36
14.67
2.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
29
7.90
14.66
1.3
1.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
149
877
3.17
14.56
22.0
5.6
e9/l
0.2
0.2
0.64
142
778
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
87
4.75
14.31
3.2
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
30
7.63
14.24
1.5
1.5
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
34
80
4.84
13.94
13.1
2.7
%
1.6
1.2
0.72
34
80
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
31
68
5.14
13.78
3.9
3.2
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
16
17
10.07
13.60
2.9
1.9
%
91.8
90.1
0.66
16
17
(3042111) Morphology [Interpretation] in Bone marrow Narrative
22
35
6.87
13.56
3.9
1.4
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
24
42
6.29
13.52
1.3
2.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
45
135
3.93
13.47
3.4
2.3
ug/l
7.6
7.4
0.02
39
118
(44790048)
17
20
9.13
13.43
2.1
1.4
—
—
—
0
0
(44806118)
17
20
9.13
13.43
2.1
1.4
—
—
—
0
0
(44790047)
17
20
9.13
13.43
2.1
1.4
—
—
—
0
0
(44790049)
17
20
9.13
13.43
2.1
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
26
7.90
13.34
1.9
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
47
5.87
13.10
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
115
4.03
12.66
2.0
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
22
8.29
12.46
1.9
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
23
42
6.00
12.40
14.0
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
95
468
2.81
12.38
9.5
3.1
e6/l
0.9
0.3
0.54
86
334
(40760888) Immunoglobulin light chains.free panel - Serum
20
32
6.78
12.23
1.5
3.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
102
524
2.76
12.22
9.9
3.0
e6/l
80.1
166.5
0.30
94
392
(3013650) Neutrophils [#/volume] in Blood by Automated count
157
1005
2.96
12.22
33.9
8.8
e9/l
5.2
4.0
5.59
151
885
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
23
43
5.86
12.10
2.2
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
12
11.45
12.07
1.3
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
26
7.45
12.04
5.3
2.4
%
15.3
15.7
—
8
11
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
26
55
5.23
12.00
1.4
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
312
2.94
11.85
7.2
3.1
ng/l
115.5
287.2
0.99
64
251
(3044290) Cell count panel - Cerebral spinal fluid
16
21
8.14
11.57
2.1
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
33
88
4.24
11.52
11.0
2.8
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
15
6
26.65
11.30
8.1
2.0
umol/l
29.3
29.2
—
15
6
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
16
22
7.76
11.14
1.4
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
14
17
8.73
10.73
1.6
2.3
e9/l
1.4
1.0
—
8
5
(3002179) Metamyelocytes/100 leukocytes in Blood
41
134
3.53
10.72
6.1
4.5
%
0.3
0.3
0.03
17
32
(3021960) Folate [Moles/volume] in Serum or Plasma
81
396
2.65
10.39
2.4
1.5
nmol/l
20.6
19.8
0.22
74
328
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
15
9.15
10.33
2.6
2.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
54
214
3.02
10.28
19.0
20.1
inr
1.4
1.3
—
8
31
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
22
46
5.20
10.25
1.9
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
90
467
2.57
10.18
9.5
2.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
12
13
9.71
9.96
16.3
2.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
16
25
6.82
9.95
4.3
2.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
100
550
2.50
9.94
5.3
3.3
mmol/l
6.3
8.0
3.09
83
455
(3017181) Myelocytes/100 leukocytes in Blood
43
152
3.27
9.91
6.9
4.4
%
0.6
0.7
0.05
21
46
(3018095) Leukocytes [#/volume] in Urine
105
600
2.43
9.49
11.9
3.5
e6/l
891.4
119.3
0.79
94
420
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
13
6
22.89
9.46
2.8
1.0
%
87.9
96.5
—
13
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
14
9.01
9.43
1.9
1.6
—
—
—
0
0
(4035726)
41
147
3.20
9.20
2.4
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
60
267
2.71
9.13
8.0
2.9
e6/l
3.7
1.8
0.49
40
147
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
21
7.05
9.00
2.6
4.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
115
698
2.36
8.91
3.0
1.9
pmol/l
94.5
91.5
0.27
77
362
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
25
6.37
8.77
1.2
1.1
u/ml
1.7
1.1
—
9
8
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
24
62
4.22
8.68
16.9
4.9
%
1.7
1.5
0.37
24
56
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
288
2.61
8.62
7.2
2.8
e6/l
2.3
0.8
1.15
42
166
(3037756) Immunofixation for Serum or Plasma
17
33
5.50
8.55
1.4
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
11
13
8.85
8.53
5.3
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
16
7.88
8.49
1.3
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
81
432
2.38
8.33
6.1
2.7
umol/l
382.4
7310.1
1.92
73
360
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
68
341
2.44
7.97
1.7
1.8
pmol/l
519.6
421.1
1.09
54
288
(4306422)
13
21
6.52
7.80
1.4
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
11
6
19.20
7.68
4.2
2.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
106
652
2.21
7.62
5.8
2.2
nmol/l
73.3
76.0
0.38
99
571
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
12
9
14.01
7.47
1.3
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
92
538
2.22
7.46
5.7
3.8
mg/mmol
22.5
6.7
2.20
71
358
(3037522) Nuclear Ab [Titer] in Serum
46
198
2.67
7.36
1.6
1.3
titre
128.0
634.9
—
5
39
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
14
26
5.68
7.35
6.1
2.4
%
55.0
58.6
0.27
14
26
(3042631) Mycobacterium sp identified in Specimen
15
30
5.29
7.29
4.0
3.8
—
—
—
0
0
(3020891) Body temperature
22
62
3.83
7.07
23.2
4.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
24
72
3.62
7.06
4.3
2.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
94
565
2.16
7.02
9.4
3.1
mmol/l
2.3
2.3
1.70
84
487
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
20
6.29
6.98
1.5
2.1
e6/l
633.2
457.1
—
5
8
(3051651) Icteric interference index of Serum or Plasma
11
8
14.38
6.97
17.2
2.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
17
6.76
6.84
1.4
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14
28
5.27
6.80
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
105
666
2.10
6.75
7.8
3.5
ng/l
106.4
46.6
0.40
93
468
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
11
9
12.78
6.65
1.9
1.6
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
174
1345
2.40
6.65
36.3
7.0
u/l
112.7
80.6
7.51
169
1256
(3007930) Methemoglobin/Hemoglobin.total in Blood
21
60
3.76
6.62
19.3
5.0
%
0.9
0.9
0.20
21
55
(3021901) Oxygen saturation in Capillary blood
14
29
5.09
6.55
6.3
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
86
511
2.12
6.52
4.5
3.1
mg/l
130.3
51.0
1.47
69
341
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
7
14.88
6.46
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
7
14.88
6.46
1.3
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
35
140
2.78
6.41
6.7
4.7
%
0.1
0.1
0.25
21
39
(3030905) Polymorphonuclear cells [#/volume] in Blood
13
26
5.25
6.31
4.2
2.3
e9/l
4.9
4.4
0.22
13
26
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
30
4.92
6.30
1.5
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
45
208
2.46
6.17
1.4
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
23
5.46
6.08
2.3
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
16
6.50
6.01
1.7
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
16
6.50
6.01
1.2
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
75
440
2.07
5.76
26.9
6.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
66
3.41
5.76
5.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
38
168
2.53
5.71
9.6
3.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
153
1156
2.06
5.70
11.2
3.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
9
7
13.33
5.63
1.1
2.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
9
7
13.33
5.63
1.1
2.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
68
3.31
5.50
5.0
1.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
8
5
16.52
5.45
2.1
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
5
16.52
5.45
2.1
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
29
614
0.39
5.45
3.2
2.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
34
4.33
5.44
13.0
4.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
18
5.77
5.37
2.2
1.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
8
11.66
5.34
2.4
1.6
u/ml
2720.4
1040.9
—
9
8
(3000570) Elastase.pancreatic [Mass/mass] in Stool
17
49
3.68
5.29
1.5
1.4
ug/g
171.6
301.7
2.34
12
31
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
0
+∞
5.23
1.0
0.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
0
+∞
5.23
1.8
0.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
6
13.76
5.12
2.1
1.7
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
9
10.36
5.07
1.3
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
9
10.36
5.07
1.7
3.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
31
133
2.55
4.94
7.2
4.8
%
0.1
0.2
0.39
18
37
(3007164) IgA [Mass/volume] in Serum or Plasma
58
328
2.04
4.82
2.1
1.4
g/l
2.4
2.6
0.29
47
199
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
81
516
1.90
4.77
6.1
2.7
ng/l
3166.2
1168.7
1.47
75
438
(3028707) Methadone [Presence] in Urine by Screen method
12
29
4.32
4.69
6.7
3.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
11
8.47
4.60
5.8
1.4
%
10.2
11.5
—
9
11
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
10
21
4.94
4.58
1.8
1.7
u/l
343.4
232.3
—
10
21
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
26
4.40
4.41
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
9
12
7.76
4.40
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
9
12
7.76
4.40
1.3
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
72
453
1.88
4.34
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
45
240
2.10
4.34
1.6
1.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
8
9
9.17
4.31
1.9
1.6
e9/l
0.3
0.1
—
8
9
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
6
11.99
4.30
1.3
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
6
11.99
4.30
2.0
1.7
—
—
—
0
0
(3015736) pH of Urine
94
645
1.80
4.27
7.5
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
13
7.16
4.20
2.6
1.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
113
824
1.76
4.14
7.8
3.4
estimate
0.0
0.0
0.00
27
158
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
7
10.27
4.04
1.3
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
14
6.65
4.02
1.4
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
114
839
1.74
4.00
8.1
3.5
estimate
0.0
0.0
0.00
23
150
(3024891) Influenza virus A+B Ag [Presence] in Specimen
14
43
3.41
3.98
1.6
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
62
383
1.86
3.91
10.2
5.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
9
15
6.20
3.85
1.2
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
8
8.99
3.80
1.3
1.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
5
12.28
3.78
1.8
1.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
5
12.28
3.78
9.3
5.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
111
824
1.70
3.67
10.4
4.7
estimate
0.0
0.0
0.00
29
158
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
19
74
2.72
3.66
4.5
3.5
u/ml
51.3
478.2
0.55
14
63
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
9
7.99
3.58
5.4
7.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
6
10.23
3.52
1.5
1.0
nmol/l
153.0
158.0
—
6
6
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
6
10.23
3.52
1.0
1.0
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
6
10.23
3.52
1.0
1.0
%
91.3
94.5
—
6
6
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
6
10.23
3.52
1.2
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
371
1.81
3.48
7.7
3.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
53
2.96
3.43
2.2
1.9
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
42
3.23
3.43
11.2
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
37
200
2.02
3.43
2.9
1.8
%
1.8
1.5
0.68
29
177
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
37
3.37
3.39
2.8
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
10
7.19
3.39
1.3
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
10
7.19
3.39
2.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
14
5.88
3.37
1.8
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
28
137
2.20
3.34
4.1
2.7
ml/min/173m2
48.3
65.7
1.04
15
55
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
7
8.77
3.28
1.5
1.1
iu/ml
150.0
103.8
—
6
7
(3014271) Vancomycin [Susceptibility]
6
7
8.77
3.28
3.2
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
9
19
4.89
3.27
5.4
1.8
pg
29.7
32.8
—
9
19
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
33
3.46
3.24
1.1
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
27
132
2.19
3.23
7.8
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
104
778
1.64
3.21
39.2
8.8
e9/l
0.0
0.0
0.78
92
645
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
7
11
6.53
3.21
5.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
22
100
2.33
3.11
2.0
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
7
12
5.98
3.04
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
12
5.98
3.04
1.7
1.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
143
2.10
3.01
7.8
3.1
—
—
—
0
0
(4062490)
8
17
4.84
2.94
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
13
5.52
2.89
2.1
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
13
5.52
2.89
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
13
5.52
2.89
1.1
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
9
6.81
2.88
2.0
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
9
6.81
2.88
2.0
1.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
140
1149
1.60
2.81
10.8
2.9
u/l
100.6
47.9
3.92
132
1071
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
6
8.49
2.76
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
6
8.49
2.76
4.0
1.8
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
6
8.49
2.76
1.0
1.2
—
—
—
0
0
(3013512) EKG study
74
526
1.61
2.72
6.0
3.6
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
152
1280
1.61
2.66
7.9
4.0
mm/h
30.2
11.7
11.39
143
1171
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
7
7.27
2.56
1.4
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
26
3.56
2.51
1.2
1.2
—
—
—
0
0
(4268621)
7
16
4.48
2.49
2.7
1.9
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
21
3.91
2.49
2.0
2.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
67
0.00
2.43
0.0
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
12
5.11
2.42
1.7
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
13
52
2.59
2.40
13.4
2.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
8
6.36
2.38
1.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
151
1704
0.64
2.38
5.9
4.6
mmol/l
3.9
4.6
10.84
136
1568
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
17
4.22
2.38
1.3
1.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
17
4.22
2.38
1.4
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
18
3.98
2.27
1.9
1.4
nmol/l
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
18
3.98
2.27
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
14
4.37
2.16
1.5
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
151
1693
0.66
2.13
5.7
4.5
mmol/l
1.2
1.4
7.21
133
1541
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
151
1691
0.66
2.09
6.2
4.7
mmol/l
6.7
6.0
3.24
135
1537
(3028300) Cannabinoids [Presence] in Urine
13
56
2.40
2.09
14.5
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
13
56
2.40
2.09
13.8
2.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
10
5.09
2.08
1.2
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
20
3.58
2.07
2.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
7
20
3.58
2.07
5.4
3.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
157
1742
0.66
2.04
5.7
5.1
mmol/l
2.2
2.7
12.41
138
1589
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
26
3.15
2.03
1.1
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
13
57
2.36
2.02
14.5
2.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
21
3.41
1.98
3.6
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
6
159
0.36
1.97
1.0
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
16
3.82
1.95
1.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
46
316
1.58
1.90
7.9
3.2
mmol/l
2.5
2.4
3.88
40
276
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
22
3.25
1.89
3.6
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
22
3.25
1.89
3.3
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
22
3.25
1.89
3.6
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
180
1933
0.62
1.86
121.3
18.9
e9/l
8.5
6.6
4.87
175
1882
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
17
3.60
1.85
1.8
1.8
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
17
3.60
1.85
1.2
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
17
3.60
1.85
1.8
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
17
3.60
1.85
1.8
1.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
180
1932
0.62
1.83
121.2
18.8
e12/l
3.9
4.5
25.57
174
1880
(3024731) MCV [Entitic volume]
180
1932
0.62
1.83
120.8
18.8
fl
90.8
91.0
0.15
175
1903
(3035941) MCH [Entitic mass]
180
1932
0.62
1.83
120.7
18.7
pg
29.7
30.4
3.74
175
1903
(3045424) Erythrocytes [Presence] in Urine
7
23
3.11
1.81
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
23
3.11
1.81
3.3
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
23
3.11
1.81
3.3
1.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
180
1930
0.63
1.78
121.4
18.8
e9/l
251.1
242.0
0.68
175
1881
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
18
3.40
1.76
1.7
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
61
2.20
1.75
3.1
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
0
46
0.00
1.73
0.0
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
7
25
2.86
1.66
2.7
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
259
1.56
1.63
1.3
1.3
iu/ml
38.0
39.5
—
8
86
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
85
1.95
1.59
1.9
2.3
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
7
26
2.75
1.59
2.7
2.2
mmol/l
105.0
106.6
—
7
26
(3033705) Calcium.ionized [Moles/volume] in Venous blood
7
26
2.75
1.59
2.7
2.2
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
7
26
2.75
1.59
2.7
2.2
mmol/l
4.2
4.1
—
7
26
(21494434) Karyotype in Bone marrow
6
20
3.05
1.59
1.2
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
57
2.17
1.58
1.3
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
60
454
1.44
1.56
9.3
3.7
estimate
0.0
0.0
0.00
23
153
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
15
3.38
1.53
1.8
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
15
3.38
1.53
5.8
7.5
nmol/l
1204.2
776.8
—
5
15
(4281824)
5
15
3.38
1.53
1.4
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
5
15
3.38
1.53
1.8
1.4
u/l
17.6
12.3
—
5
15
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
15
3.38
1.53
1.8
1.7
u/l
24.8
12.4
—
5
15
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
5
15
3.38
1.53
16.6
10.5
nmol/l
2276.0
1345.7
—
5
15
(3019150) Specific gravity of Urine by Refractometry
51
378
1.45
1.48
9.1
3.8
kg/l
1.0
1.0
—
6
58
(3017732) Neutrophils [#/volume] in Blood
18
103
1.81
1.46
4.0
2.8
e9/l
3.2
3.7
—
10
75
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
16
3.17
1.44
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
15
81
1.91
1.44
6.7
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
201
1.57
1.39
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
463
0.66
1.37
3.2
3.0
ug/l
0.8
0.8
0.07
28
295
(1761482) Bacteria [#/volume] in Urine by Culture
10
47
2.18
1.36
5.7
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
9
43
2.14
1.32
2.3
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
6
24
2.54
1.31
3.2
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
18
2.82
1.29
1.0
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
8
36
2.27
1.25
6.1
2.1
g/l
120.1
127.9
—
8
25
(3027944) Amphetamines [Presence] in Urine
11
56
2.02
1.24
16.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
49
2.09
1.24
2.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
49
2.09
1.24
2.2
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
49
2.09
1.24
2.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
19
2.67
1.22
1.2
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
19
2.67
1.22
1.4
3.6
u/ml
19.8
44.7
—
5
19
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
50
636
0.72
1.20
5.0
4.6
%
21.6
22.0
0.05
26
307
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
5
20
2.53
1.15
3.6
3.3
u/ml
27.4
15.0
—
5
20
(3044889) 12 lead EKG panel
137
1228
1.31
1.11
6.7
3.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
153
1649
0.76
1.03
6.7
4.0
mmol/l
1.6
1.3
2.38
137
1487
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
48
1.91
1.02
1.2
1.0
—
3.9
—
0
6
(3050129) First trimester maternal screen panel - Serum or Plasma
0
29
0.00
0.98
0.0
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
29
0.00
0.98
0.0
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
46
361
1.35
0.97
1.2
1.2
u/ml
1.7
0.8
—
8
91
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
245
1.41
0.96
1.3
1.3
u/ml
2.9
15.4
—
7
107
(3041096) Erythrocytes [Presence] in Urine by Automated
58
474
1.30
0.93
6.9
3.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
80
682
1.27
0.92
3.5
2.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
8
42
1.94
0.89
1.1
1.4
—
383.7
—
0
22
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
656
1.27
0.89
8.7
3.5
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
176
1850
0.76
0.85
99.8
15.0
umol/l
110.6
79.1
4.54
176
1850
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
31
1.96
0.85
7.2
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
153
1631
0.80
0.79
76.2
12.0
ml/min/173m2
71.6
80.5
2.70
136
1348
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
26
0.00
0.79
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
17
116
1.50
0.77
7.1
2.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
116
1.50
0.77
1.9
1.7
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
24
2.11
0.75
3.4
1.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
43
1.65
0.67
1.0
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
71
807
0.82
0.66
5.1
4.8
ug/l
2.3
2.4
0.05
63
711
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
112
1025
1.19
0.60
4.3
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
55
473
1.22
0.58
2.9
1.6
mmol/l
1.9
1.4
2.04
50
404
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
39
1.55
0.53
1.8
1.2
—
—
—
0
0
(3000492) Spirometry study
19
144
1.35
0.52
1.3
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
46
1.54
0.49
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
130
1220
1.16
0.48
4.9
3.7
pmol/l
14.8
14.8
0.06
118
1087
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
154
1612
0.85
0.47
9.4
5.9
mmol/mol
45.5
40.3
3.62
144
1484
(40768443) Skin Pathology biopsy report
11
77
1.45
0.46
1.6
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
78
1.43
0.44
2.1
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
31
1.63
0.43
1.4
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
32
1.58
0.42
5.8
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
176
1817
0.84
0.41
76.3
11.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
13
171
0.75
0.41
2.0
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
179
1732
1.18
0.39
100.6
12.4
mg/l
39.3
23.7
9.59
171
1369
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
177
0.78
0.34
1.4
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
220
1.21
0.33
21.0
6.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
7
97
0.71
0.31
1.4
1.1
—
138.8
—
0
37
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
180
1845
0.87
0.31
42.1
9.9
u/l
31.4
27.4
1.16
174
1780
(4094501)
5
40
1.26
0.22
1.0
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
2.3
—
7.1
—
0
12
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
4.6
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
227
1.11
0.15
4.1
4.4
%
34.2
30.6
0.65
14
141
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
118
0.84
0.14
2.3
2.5
—
15.9
—
0
5
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
9
107
0.83
0.13
1.4
1.3
—
37.0
—
0
10
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
153
1556
0.95
0.11
5.9
4.4
mu/l
2.0
1.9
0.17
136
1379
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
14
156
0.89
0.10
2.0
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
60
0.83
0.08
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
62
0.80
0.08
1.2
2.0
—
—
—
0
0
(4010399)
14
127
1.11
0.08
1.4
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
7
80
0.87
0.07
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
83
0.84
0.07
1.1
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
158
1563
1.04
0.06
101.6
13.1
%
32.3
40.1
10.21
93
1106
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
26
268
0.97
0.02
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
14
139
1.01
0.00
2.0
2.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
13
125
1.04
0.00
1.3
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
16.6
—
0
5
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
8.2
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
22.8
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
16.8
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
91
0.99
0.00
1.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
59
0.84
0.00
2.8
2.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
2.4
—
65.0
—
0
5
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
15.0
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AB1_SEPSIS_FUNGAL_EXPL – Explicit fungal Sepsis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).